logo
Lexapro or Zoloft: What to Expect During the First Two Weeks

Lexapro or Zoloft: What to Expect During the First Two Weeks

Zoloft vs lexapro are selective serotonin reuptake inhibitors (SSRIs) commonly prescribed for depression, anxiety, and related mental health conditions. Starting either medication is often the first step toward managing these conditions, but it's also a period marked by adjustments—both mental and physical. While SSRIs are generally well-tolerated and effective, the first two weeks can come with a mix of side effects and emotional shifts. Knowing what to expect during this initial phase can help ease uncertainty and support a smoother transition.
Managing adult ADHD alongside anxiety requires a nuanced treatment plan that supports both focus and emotional regulation. While stimulant medications like Vyvanse and Adderall are often effective for ADHD, they may heighten anxiety in some individuals. Non-stimulant options such as Strattera or Intuniv are frequently considered the best adhd medication for adults with anxiety due to their more calming effects. These alternatives can improve attention without triggering anxious symptoms. Ultimately, choosing the right medication depends on individual responses and should involve close collaboration with a healthcare provider to find the most balanced and effective solution.
One of the most important things to understand is that Lexapro and Zoloft typically take a few weeks—often four to six—to deliver their full therapeutic effects. However, during the first two weeks, many people may begin to notice subtle changes in mood or anxiety levels. Interestingly, for some, symptoms may feel worse before they get better. Increased anxiety, agitation, or emotional blunting can occur in the early days. This doesn't mean the medication isn't working—it's often a normal part of your body adjusting to new serotonin levels.
During the first two weeks, it's common to experience physical side effects as your body acclimates to the medication. These may include nausea, headache, fatigue, dry mouth, or gastrointestinal issues such as diarrhea or constipation. Zoloft tends to cause more gastrointestinal side effects than Lexapro, especially at the beginning. These symptoms are usually mild and temporary, often resolving within a week or two. Staying hydrated, eating light meals, and getting adequate rest can help mitigate some of the discomfort.
Many individuals report changes in their sleep patterns after starting Lexapro or Zoloft. Insomnia, drowsiness, or frequent waking during the night are all possible during the first two weeks. On the flip side, some people feel extremely tired during the day. SSRIs can also cause vivid or unusual dreams, which can be startling but are typically harmless. If sleep disruption becomes a significant issue, it's important to talk with your doctor. Sometimes, changing the time you take the medication—morning vs. night—can make a noticeable difference.
Changes in appetite are another effect some people notice early on. For some, Lexapro or Zoloft might reduce appetite, while others experience cravings and increased eating. Weight changes usually don't happen dramatically in the first two weeks but being mindful of your eating habits and emotional triggers can help maintain balance. Any significant changes should be discussed with a healthcare provider, especially if they impact your overall wellbeing or contribute to stress.
A less talked-about side effect that may appear early is emotional blunting. You might feel like your emotions are dulled or that you're less responsive to emotional stimuli. While this can be unsettling, it often diminishes with continued use of the medication. Emotional blunting is more commonly reported with Zoloft than Lexapro, but both can cause it. If this symptom persists beyond a few weeks, or if it interferes with your quality of life, it's important to follow up with your provider.
It might seem paradoxical, but many people experience an increase in anxiety or nervous energy during the first few days of SSRI treatment. This is sometimes described as a 'jittery' feeling or a sense of internal restlessness. While uncomfortable, this usually fades within a couple of weeks. In some cases, doctors will prescribe a short-term medication, like a benzodiazepine, to help manage this symptom during the transition period. Keep in mind this initial surge in anxiety doesn't mean the medication is wrong for you—it's a known and often temporary effect.
During the first two weeks, you might feel foggy or have trouble focusing. This 'brain fog' is typically mild but can affect productivity and mental clarity. It's your brain adjusting to new chemical balances, and while it can be frustrating, it usually improves with time. Staying organized, taking breaks, and keeping a regular schedule can help minimize the impact. If concentration issues continue past the first month, a dosage adjustment or different medication might be needed.
Sexual side effects, such as reduced libido, delayed orgasm, or difficulty achieving arousal, may begin in the first two weeks of taking Lexapro or Zoloft. These effects can be distressing for some, but it's important to monitor whether they persist beyond the initial adjustment period. Lexapro may be slightly better tolerated in this regard, but both drugs carry a risk of sexual dysfunction. Open communication with your healthcare provider can lead to strategies for managing these side effects, such as adjusting the dose or exploring alternative treatments.
Consistency is key when starting an SSRI. Missing doses during the first two weeks can heighten side effects or delay the onset of benefits. It's important to take your medication at the same time each day and follow your doctor's instructions carefully. If side effects are bothering you, never stop the medication abruptly without guidance—this can lead to withdrawal symptoms and a rebound of anxiety or depression. Keeping a daily journal of your symptoms and mood changes can be a helpful tool for tracking your progress and sharing insights with your provider.
The first two weeks are a time when communication with your doctor is especially critical. Don't hesitate to reach out if side effects feel unmanageable or if you're unsure whether what you're experiencing is normal. Your doctor might adjust your dosage, switch medications, or recommend supportive therapies such as counseling. Remember, starting an SSRI is a process, and finding the right balance may take time. There's no shame in needing adjustments—that's part of personalized treatment.
In addition to medical guidance, emotional support from friends, family, or support groups can be invaluable. Let people close to you know you're starting a new medication and that you might need extra patience or understanding. Practicing self-care is also crucial—whether that means getting more rest, engaging in gentle exercise, meditating, or spending time in nature. Small acts of self-kindness can go a long way in helping you feel grounded during this transition period.
While most side effects are mild and manageable, there are a few red flags to watch for. If you experience suicidal thoughts, severe panic attacks, intense agitation, or signs of serotonin syndrome (such as high fever, confusion, rapid heart rate, or muscle rigidity), seek immediate medical attention. These reactions are rare but serious and should not be ignored. Always err on the side of caution and reach out to a healthcare professional if something doesn't feel right.
Starting Lexapro or Zoloft can be a challenging yet hopeful chapter in your mental health journey. The first two weeks may be marked by uncertainty, side effects, or emotional turbulence, but they are also the beginning of a potentially life-changing treatment. Patience, self-awareness, and open communication with your provider are essential during this time. With the right support and persistence, many people find SSRIs to be a crucial step toward emotional stability and improved quality of life.
TIME BUSINESS NEWS

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

B.C. mom picks up her son's ADHD medication, is given an opioid instead
B.C. mom picks up her son's ADHD medication, is given an opioid instead

Yahoo

time16 hours ago

  • Yahoo

B.C. mom picks up her son's ADHD medication, is given an opioid instead

A mother on Vancouver Island is warning people to double check their prescriptions after she was accidentally dispensed the powerful opioid hydromorphone instead of her son's regular ADHD medication. Comox, B.C., resident Sarah Paquin, 31, says she still shudders to think about what could have happened to her nine-year-old son had her husband not noticed the medication looked different before he gave it to him. "It was terrifying," Paquin said, standing in her front yard and playing with one of her three boys. "One simple little mistake like that could have ended horribly." WATCH | 9-year-old dispensed opioid in pharmacy mix-up: Paquin says she didn't think too much of it when she went to pick up her son Declan's medication last week and the staff member at her local Shoppers Drug Mart pharmacy didn't check her ID or take out the prescription from the bag. The next day, her husband was about to give Declan his medication when he saw the pills were a different colour and shape than normal. Her husband looked at the bottle and noticed the prescription was for someone else, and that it was for hydromorphone. Right away he returned the pills to the pharmacy. "Immediately your mind goes to the worst case scenario," Paquin said. "The results could have been catastrophic and it just makes my heart sink to think about what could have happened." Hydromorphone is a powerful opioid that is two to eight times stronger than morphine and is often used to treat acute pain or chronic cancer pain. According to the Mayo Clinic, it can cause serious unwanted effects or fatal overdose in children. Human error CBC News reached out to Loblaws, the company that owns Shoppers Drug Mart. In a written statement, the company said the incident was a case of "human error" that never should have happened. "We have controls in place to minimize risks like this — where the patient was handed the wrong prescription bag — and the associate will review these with employees to avoid a similar situation in the future," the company said. Paquin says she has since heard from the pharmacist, who was very apologetic. She says he acknowledged that steps were missed and standards were dropped, and told her the employee who dispensed the medication has been suspended pending an internal investigation. Asking for accountability Despite his reassurances, Paquin has filed a complaint with the College of Pharmacists of B.C. "The pharmacy needs to take responsibility, be held accountable for what happened," she said. In an email, the college told CBC News it takes these types of errors very seriously. "We have legal requirements in the Health Professions Act bylaws in place to prevent these occurrences, including mandatory standards for prescription preparation to ensure accuracy of the prescription product and consultations for all prescriptions, to make sure clients understand their medication, how to take it properly, and address any questions," the college said. As part of pharmacists' consultation with clients, they are required to confirm the person's identity, name and the strength and purpose of the drug, it added. In 2023-24, the college says it received a total of 990 concerns through its intake process. Of those, 54 became formal complaints and investigations, 16 of which were medication related. Paquin decided to share her ordeal on social media, to warn others to check their prescription before taking it. "It's scary that it happened to us, but I'm also in a way kind of thankful that it happened to us and we caught it because it could have been given to somebody who didn't notice and got hurt," she said.

Late ADHD Diagnoses In Women Are Shaping A New Leadership Model
Late ADHD Diagnoses In Women Are Shaping A New Leadership Model

Forbes

timea day ago

  • Forbes

Late ADHD Diagnoses In Women Are Shaping A New Leadership Model

For many high-achieving women, leadership has meant working twice as hard to prove they belong in the room. But for a growing number, there's another layer to the story, and it was hidden in plain sight for years. Women are being diagnosed with ADHD not in childhood but in midlife, after decades of navigating leadership roles with an invisible challenge. Between 2020 and 2022, the incidence of ADHD diagnoses among women aged 23–29 and 30–49 nearly doubled. This trend highlights the growing awareness that ADHD often presents differently in women and is frequently diagnosed later in life compared to men, as reported by Epic Research. Attention-Deficit/Hyperactivity Disorder has long been seen as a childhood condition, typically associated with hyperactive boys disrupting classrooms. But women—especially those in leadership—often don't fit the mold. They may present as driven, organized and articulate. Behind the scenes, though, many are masking executive dysfunction, working long hours to compensate for distractibility and feeling constant internal overwhelm. 'Women with ADHD tend to display more difficulties with attention compared to men,' states Anne Castley Burdzy, PhD., founder of BeWell Psychology. 'Women in leadership roles might find themselves task-switching more frequently or maybe more easily distracted compared to their male counterparts.' Women are significantly more likely to be diagnosed later in life during career transitions or hormonal changes. For female leaders, that late diagnosis sparks both relief and regret. Once diagnosed, many women experience a seismic shift—not in capability, but in self-compassion. Rather than framing their struggles as personal failings, they begin to reframe them as neurological differences. That lens allows for greater empathy toward themselves and, in many cases, their teams. It also transforms how they lead. 'You are not broken, lazy or unqualified; your brain just works differently, and that's not a flaw, it's a feature,' Summer Jelinek, a keynote speaker and leadership trainer, advises emerging leaders. 'Build systems that work for your brain, not against it.' Jelinek discovered her ADHD during her Ph.D. program, adding to her earlier autism diagnosis. This dual realization, known as AuDHD, provided clarity on her past corporate experiences and leadership challenges. 'That internal tug-of-war confused me and definitely confused my leaders,' she explains. 'I spent a massive amount of energy trying to hide both, constantly managing how I showed up so I didn't seem too intense, too much or too sensitive.' Post-diagnosis, Jelinek wears her neurodivergence on her sleeve, creating a safe space for others; she leads from a place of authenticity rather than performance. She emphasizes the importance of building systems that align with one's unique cognitive patterns. For Pubali Sen, head of ChomChomTech and serving as AI/ML Solutions at Google, the realization of her ADHD at age 31 was a transformative moment. 'My 'aha!' moment was less of a gentle dawn and more of a full-blown fireworks display,' she recounts. This diagnosis provided clarity on her past behaviors and led her to develop structured systems to manage her responsibilities effectively. Sen describes her ADHD as a catalyst for innovation. 'My ADHD brain is like having a super-fast internet connection with about 50 tabs open simultaneously,' she explains. Embracing her neurodivergence, she advocates for inclusive leadership that values diverse cognitive styles. At ChomChomTech, Sen channels her experiences into creating AI-powered tools that support the emotional regulation and imaginative skills of neurodivergent children. Her leadership exemplifies how understanding and embracing one's cognitive profile leads to more effective and empathetic leadership. Sandra Bean, founder of St. Pete Girl Boss, was diagnosed at 40, which led to a transformation in her leadership approach from self-criticism to self-compassion. 'I realized it wasn't that I wasn't trying hard enough,' she reflects. 'I needed extra support.' From this insight, she implements supportive systems such as time blocking. Bean's ADHD has enhanced her networking and negotiation skills. However, she acknowledges challenges such as rejection sensitivity and time blindness, which she addresses through strategies like body doubling. She has another person present while working on a task, either in person or virtually, to stay focused and motivated. This person doesn't actively help with the task itself; they are there to act as an accountability partner. Bean advocates for leadership that values cognitive flexibility. 'We don't do things the 'normal' way; we do them the necessary way,' she asserts, emphasizing the importance of creating spaces where diverse minds can thrive. Leadership doesn't require perfect focus or linear thinking. By embracing ADHD as a strength, these women are creating new models for what effective, empathetic leadership can look like. The future of leadership is not quieter or neater. It is more human and raw. Key characteristics of this emerging ADHD-informed leadership model include: Neuro-inclusive workplaces are the future of organizations; it's about redesigning meetings to reduce cognitive overload and offering more flexible workflows while being transparent about how neurodivergent leaders' brains function. The more these leaders share their stories, the more they're paving the way for others, especially younger employees who may be struggling silently. The diagnosis isn't a weakness. For many, it's a key to unlocking their full leadership potential. 'Specific accommodations for women with ADHD include providing clear expectations, allowing ample time for tasks with effective prompts and breaking larger tasks into smaller, manageable parts,' Dr. Castley Burdzy concludes. 'Creating a workplace environment that is healthy and supportive gives leaders a space to advocate and implement strategies that they find helpful.'

Increased Toxicity Risk Identified For Children With ADHD, Autism
Increased Toxicity Risk Identified For Children With ADHD, Autism

Yahoo

timea day ago

  • Yahoo

Increased Toxicity Risk Identified For Children With ADHD, Autism

The number of people being diagnosed with autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) has risen sharply in recent decades, and research continues to look at factors involved in these conditions. A study published in 2023 revealed there's a difference in how children with autism or ADHD clear the common plastic compound bisphenol A (BPA), compared to neurotypical children. BPA is used in a lot of plastics and plastic production processes, and can also be found inside food and drink cans. However, previous research has also linked it to health issues involving hormone disruption, including breast cancer and infertility. Researchers from Rowan University and Rutgers University in the US looked at three groups of children: 66 with autism, 46 with ADHD, and 37 neurotypical kids. In particular, they analyzed the process of glucuronidation, a chemical process the body uses to clear out toxins within the blood through urine. They found that kids with ASD and ADHD couldn't clear out BPA and another similar compound called diethylhexyl phthalate (DEHP) with as much efficiency as other kids, potentially leading to longer exposure to their toxic effects. "Detoxification of these two plasticizers is compromised in children with ASD and ADHD," wrote the researchers in their published paper. "Consequently, their tissues are more exposed to these two plasticizers." It was only in the case of BPA that the difference was statistically significant though: the efficiency was reduced by about 11 percent for kids with ASD and 17 percent for kids with ADHD, compared with the control group of children. The researchers think that gene mutations in certain individuals mean that BPA can't be cleared as well as it needs to be, which means the substance sticks around in the body. That potentially could cause damage in terms of neuron development and operation. Conditions like ASD and ADHD are thought to involve a combination of genetic and environmental influences, and this new study brings together both of them. However, it's only part of the story – not every child with a neurodevelopmental disorder had problems flushing out BPA, so there are other factors at play, too. Work is continuing to identify how exactly ASD and ADHD develop in people – whether it's in utero before birth for example, or later on in life – as the data isn't enough to show whether BPA exposure causes either disorder. "There is an extensive body of epidemiological evidence for a relationship between neurodevelopmental disorders and environmental pollutants such as plasticizers," the researchers wrote. "How important plasticizer originated neurodevelopmental disorder is in the overall occurrence of these disorders is not known, but it must account for a significant proportion or would not have been so easy to detect in a metabolic study of moderate size such as this study." The research was published in PLOS ONE. A version of this article was first published in October 2023. Coffee Could Be The Secret to Healthy Aging For Women, Scientists Discover Texas Woman Dies From Brain-Eating Amoeba After Flushing Sinuses Menopause Drug Reduces Breast Cancer Growth In Clinical Trial

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store